Welcome To Nutrify Snips

Physta® (standardized Eurycoma longifolia extract) was evaluated in a 12-week randomized, double-blind, placebo-controlled trial involving 138 women aged 40–55 with menopausal symptoms. Participants received either 50 mg, 100 mg, or placebo. The 100 mg dose delivered the most meaningful effects, reducing overall MENQOL scores by 33.9 percent and improving physical and sexual domains by more… Read More

A new study published in Neurochemistry International unveils a breakthrough in the search for safer and more accessible Alzheimer’s disease (AD) treatments. Researchers from Kindai University report that oral arginine—a naturally occurring amino acid—can effectively suppress amyloid β (Aβ) aggregation, a key driver of AD pathology. While current antibody-based therapies target Aβ, their limited effectiveness,… Read More

A 12-week study on healthy men tested whether creatine causes hair loss. Participants took either creatine or a placebo. Researchers measured testosterone, DHT, and hair health using advanced tools. Results showed no increase in DHT and no negative changes in hair density, thickness, or follicle count in the creatine group. Hormone changes were similar in… Read More

This study explores the potential of novel molecules that can act as copper chelators to treat Alzheimer’s disease. Eight imines L03-10 and one quinoline-based compound L11 were synthesized, characterized, and evaluated as compounds that can act to reverse neurodegeneration in vivo. Their ability to extract copper from the Cu-β-amyloid complex, a key factor in Alzheimer’s… Read More

A 12-week randomized, double-blind, placebo-controlled study in women aged 30 to 66 evaluated a standardized four-botanical nutricosmetic blend, Eternalyoung (225 mg/day), for visible skin aging. The ingredient produced steady improvements in key facial parameters, especially on the forehead. Wrinkle volume dropped by 23.3% at week 12 while the placebo group showed a 13.6% increase. Wrinkle… Read More